Good evening :)
Switch to

Aurobindo Pharma Ltd

AUROPHARMA
Health CarePharmaceuticals
LargecapWith a market cap of ₹25,420 cr, stock is ranked 110
High RiskStock is 3.01x as volatile as Nifty
395.8038.05 (-8.77%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Current price is less than the intrinsic value

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has been generating better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

No Red Flags
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low

Health CarePharmaceuticals
LargecapWith a market cap of ₹25,420 cr, stock is ranked 110
High RiskStock is 3.01x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
9.80
PB RatioPB Ratio
1.66
Dividend YieldDiv. Yield
0.57%
Sector PESector PE
26.89
Sector PBSector PB
2.98
Sector Div YldSctr Div Yld
0.77%

Forecast & RatingsDetailed Forecast 

77%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Brands

Aurobindo Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201620172018201913.9515.0816.4919.562.022.302.422.36
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates
Announced OnNov 13, 2019

Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'. | Download

Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'. | Download

Dividend
Announced OnNov 13, 2019

Aurobindo Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 12, 2019, has inter alia, transacted the following businesses: 1. Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. | Download

Aurobindo Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 12, 2019, has inter alia, transacted the following businesses: 1. Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. | Download

Cash Dividend
Ex. DateNov 20, 2018

Interim • Div/Share: ₹ 1.25

See all events

Tickertape provides data, information & content for Indian stocks, ETFs & indices.

Data powered byPrices shown are delayed by 15 minutes© Tickertape 2019